{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T18:40:57Z","timestamp":1775846457574,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-024-04155-9","type":"journal-article","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T08:03:36Z","timestamp":1728720216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mediation effect analysis of lipoprotein levels on BMI and cardiovascular outcomes in patients with heart failure"],"prefix":"10.1186","volume":"24","author":[{"given":"Yi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baochuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heyu","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,12]]},"reference":[{"issue":"1","key":"4155_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/ehf2.14182","volume":"10","author":"AK Roalfe","year":"2023","unstructured":"Roalfe AK, Taylor CJ, Hobbs FDR. Long term changes in health-related quality of life for people with heart failure: the ECHOES study. ESC Heart Fail. 2023;10(1):211\u201322.","journal-title":"ESC Heart Fail"},{"issue":"8","key":"4155_CR2","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP, Commodore-Mensah Y, et al. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022;145(8):e153\u2013639.","journal-title":"Circulation"},{"issue":"21","key":"4155_CR3","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","volume":"143","author":"TM Powell-Wiley","year":"2021","unstructured":"Powell-Wiley TM, Poirier P, Burke LE, Despr\u00e9s JP, Gordon-Larsen P, Lavie CJ, Lear SA, Ndumele CE, Neeland IJ, Sanders P, et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;143(21):e984\u20131010.","journal-title":"Circulation"},{"key":"4155_CR4","doi-asserted-by":"crossref","unstructured":"Niderla-Bieli\u0144ska J, \u015acie\u017cy\u0144ska A, Moskalik A, Jankowska-Steifer E, Bartkowiak K, Bartkowiak M, Kiernozek E, Podg\u00f3rska A, Ciszek B, Majchrzak B et al: A Comprehensive miRNome Analysis of Macrophages Isolated from db\/db Mice and Selected miRNAs Involved in Metabolic Syndrome-Associated Cardiac Remodeling. Int J Mol Sci 2021, 22(4).","DOI":"10.3390\/ijms22042197"},{"issue":"2","key":"4155_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.pcad.2018.05.005","volume":"61","author":"TB Horwich","year":"2018","unstructured":"Horwich TB, Fonarow GC, Clark AL. Obesity and the Obesity Paradox in Heart Failure. Prog Cardiovasc Dis. 2018;61(2):151\u20136.","journal-title":"Prog Cardiovasc Dis"},{"issue":"5","key":"4155_CR6","volume":"14","author":"G Shalaby","year":"2022","unstructured":"Shalaby G, Samarin K, Alabbasi R, Fallatah AA, Roblah T, Abdulwahab RA, Althomali RN, Babateen EM, Alhodian FY, Khaled S. Obesity Influences on Patients With Non-valvular Cardiomyopathy in Relation to Early In-Hospital Outcomes and Health System Burden. Cureus. 2022;14(5): e24859.","journal-title":"Cureus"},{"key":"4155_CR7","unstructured":"\u90dd\u7d20\u82b3, \u4faf\u7fe0\u7ea2, \u88f4\u5a1f\u6167, \u5189\u7389\u7434, \u5f20\u6f8d, \u6d66\u4ecb\u9e9f: \u4f53\u91cd\u6307\u6570\u5bf9\u6162\u6027\u5fc3\u529b\u8870\u7aed\u60a3\u8005\u5168\u56e0\u6b7b\u4ea1\u98ce\u9669\u7684\u9884\u6d4b\u4f5c\u7528. \u4e2d\u56fd\u5faa\u73af\u6742\u5fd7. 2013;28(01):51\u20134."},{"key":"4155_CR8","unstructured":"\u5434\u7a77, \u674e\u6167, \u4efb\u598d, \u5f20\u51e4\u5982: \u4f53\u8d28\u91cf\u6307\u6570\u5bf9\u6162\u6027\u5fc3\u529b\u8870\u7aed\u60a3\u8005\u9884\u540e\u7684\u5f71\u54cd. \u5185\u79d1\u7406\u8bba\u4e0e\u5b9e\u8df5. 2016;11(03):176\u20139."},{"issue":"1","key":"4155_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12944-022-01694-y","volume":"21","author":"C Abrahams","year":"2022","unstructured":"Abrahams C, Woudberg NJ, Lecour S. Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage? Lipids Health Dis. 2022;21(1):85.","journal-title":"Lipids Health Dis"},{"issue":"9167","key":"4155_CR10","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1016\/S0140-6736(98)09286-1","volume":"353","author":"J Niebauer","year":"1999","unstructured":"Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-Wilson PA, Coats AJ, Anker SD. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet. 1999;353(9167):1838\u201342.","journal-title":"Lancet"},{"issue":"18","key":"4155_CR11","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, et al. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895\u20131032.","journal-title":"Circulation"},{"key":"4155_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-publhealth-032315-021402","volume":"37","author":"TJ VanderWeele","year":"2016","unstructured":"VanderWeele TJ. Mediation Analysis: A Practitioner\u2019s Guide. Annu Rev Public Health. 2016;37:17\u201332.","journal-title":"Annu Rev Public Health"},{"issue":"36","key":"4155_CR13","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599\u2013726.","journal-title":"Eur Heart J"},{"issue":"15","key":"4155_CR14","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1093\/eurjpc\/zwaa147","volume":"28","author":"NL Bragazzi","year":"2021","unstructured":"Bragazzi NL, Zhong W, Shu J, Abu Much A, Lotan D, Grupper A, Younis A, Dai H. Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017. Eur J Prev Cardiol. 2021;28(15):1682\u201390.","journal-title":"Eur J Prev Cardiol"},{"issue":"10","key":"4155_CR15","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1161\/CIRCRESAHA.121.318172","volume":"128","author":"VL Roger","year":"2021","unstructured":"Roger VL. Epidemiology of Heart Failure: A Contemporary Perspective. Circ Res. 2021;128(10):1421\u201334.","journal-title":"Circ Res"},{"key":"4155_CR16","unstructured":"\u4e2d\u56fd\u5fc3\u8840\u7ba1\u5065\u5eb7\u4e0e\u75be\u75c5\u62a5\u544a2020\u6982\u8981. \u4e2d\u56fd\u5faa\u73af\u6742\u5fd7. 2021;36(06):521\u201345."},{"issue":"11","key":"4155_CR17","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.120.316101","volume":"126","author":"ME Pich\u00e9","year":"2020","unstructured":"Pich\u00e9 ME, Tchernof A, Despr\u00e9s JP. Obesity Phenotypes, Diabetes, and Cardiovascular Diseases. Circ Res. 2020;126(11):1477\u2013500.","journal-title":"Circ Res"},{"key":"4155_CR18","first-page":"1","volume":"360","author":"CM Hales","year":"2020","unstructured":"Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017\u20132018. NCHS Data Brief. 2020;360:1\u20138.","journal-title":"NCHS Data Brief"},{"key":"4155_CR19","unstructured":"\u4e2d\u56fd\u5c45\u6c11\u8425\u517b\u4e0e\u6162\u6027\u75c5\u72b6\u51b5\u62a5\u544a (2020\u5e74) . \u8425\u517b\u5b66\u62a5. 2020;42(06):521."},{"key":"4155_CR20","doi-asserted-by":"crossref","unstructured":"The Lancet Diabetes E: Should we officially recognise obesity as a disease? Lancet Diabetes Endocrinol 2017, 5(7):483.","DOI":"10.1016\/S2213-8587(17)30191-2"},{"key":"4155_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.855525","volume":"9","author":"G Elbaz-Greener","year":"2022","unstructured":"Elbaz-Greener G, Rozen G, Carasso S, Yarkoni M, Wijeysundera HC, Alcalai R, Gotsman I, Rahamim E, Planer D, Amir O. The Relationship Between Body Mass Index and In-hospital Survival in Patients Admitted With Acute Heart Failure. Front Cardiovasc Med. 2022;9: 855525.","journal-title":"Front Cardiovasc Med"},{"key":"4155_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2147\/VHRM.S168946","volume":"15","author":"S Carbone","year":"2019","unstructured":"Carbone S, Canada JM, Billingsley HE, Siddiqui MS, Elagizi A, Lavie CJ. Obesity paradox in cardiovascular disease: where do we stand? Vasc Health Risk Manag. 2019;15:89\u2013100.","journal-title":"Vasc Health Risk Manag"},{"key":"4155_CR23","doi-asserted-by":"crossref","unstructured":"De Bandt JP, Monin C: Obesity, Nutrients and the Immune System in the Era of COVID-19. Nutrients 2021, 13(2).","DOI":"10.3390\/nu13020610"},{"issue":"1","key":"4155_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41392-020-0114-1","volume":"5","author":"X Palomer","year":"2020","unstructured":"Palomer X, Rom\u00e1n-Azcona MS, Pizarro-Delgado J, Planavila A, Villarroya F, Valenzuela-Alcaraz B, Crispi F, Sep\u00falveda-Mart\u00ednez \u00c1, Miguel-Escalada I, Ferrer J, et al. SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation. Signal Transduct Target Ther. 2020;5(1):14.","journal-title":"Signal Transduct Target Ther"},{"issue":"16","key":"4155_CR25","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, B\u00f6hm M, Brunner-La Rocca HP, Choi DJ, Chopra V, Chuquiure-Valenzuela E, et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med. 2021;385(16):1451\u201361.","journal-title":"N Engl J Med"},{"issue":"3","key":"4155_CR26","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0735-1097(01)01448-6","volume":"38","author":"TB Horwich","year":"2001","unstructured":"Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001;38(3):789\u201395.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"4155_CR27","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.mayocp.2016.11.001","volume":"92","author":"S Carbone","year":"2017","unstructured":"Carbone S, Lavie CJ, Arena R. Obesity and Heart Failure: Focus on the Obesity Paradox. Mayo Clin Proc. 2017;92(2):266\u201379.","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"4155_CR28","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1007\/s00392-021-01822-1","volume":"110","author":"N Marcks","year":"2021","unstructured":"Marcks N, Aimo A, Januzzi JL Jr, Vergaro G, Clerico A, Latini R, Meessen J, Anand IS, Cohn JN, Gravning J, et al. Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data. Clin Res Cardiol. 2021;110(8):1280\u201391.","journal-title":"Clin Res Cardiol"},{"issue":"11","key":"4155_CR29","doi-asserted-by":"publisher","first-page":"568","DOI":"10.14423\/SMJ.0000000000001174","volume":"113","author":"RD Gajulapalli","year":"2020","unstructured":"Gajulapalli RD, Kadri A, Gad M, Chahine J, Nusairat L, Rader F. Impact of Obesity in Hospitalized Patients with Heart Failure: A Nationwide Cohort Study. South Med J. 2020;113(11):568\u201377.","journal-title":"South Med J"},{"issue":"21","key":"4155_CR30","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009664","volume":"7","author":"A Pandey","year":"2018","unstructured":"Pandey A, Berry JD, Drazner MH, Fang JC, Tang WHW, Grodin JL. Body Mass Index, Natriuretic Peptides, and Risk of Adverse Outcomes in Patients With Heart Failure and Preserved Ejection Fraction: Analysis From the TOPCAT Trial. J Am Heart Assoc. 2018;7(21): e009664.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"4155_CR31","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10741-018-09766-x","volume":"24","author":"M Tadic","year":"2019","unstructured":"Tadic M, Cuspidi C. Obesity and heart failure with preserved ejection fraction: a paradox or something else? Heart Fail Rev. 2019;24(3):379\u201385.","journal-title":"Heart Fail Rev"},{"key":"4155_CR32","doi-asserted-by":"crossref","unstructured":"Giordani S, Marassi V, Placci A, Zattoni A, Roda B, Reschiglian P: Field-Flow Fractionation in Molecular Biology and Biotechnology. Molecules 2023, 28(17).","DOI":"10.3390\/molecules28176201"},{"key":"4155_CR33","doi-asserted-by":"publisher","first-page":"2906189","DOI":"10.1155\/2022\/2906189","volume":"2022","author":"AI Burguete-Garc\u00eda","year":"2022","unstructured":"Burguete-Garc\u00eda AI, Ram\u00edrez Valverde AG, Espinoza-Le\u00f3n M, V\u00e1zquez IS, Estrada Ram\u00edrez EY, Maldonado-L\u00f3pez I, Mart\u00ednez AL, Diaz Ben\u00edtez CE, Araujo RK, Fern\u00e1ndez-Madinaveitia D, et al. Severe Quantitative Scale of Acanthosis Nigricans in Neck is Associated with Abdominal Obesity, HOMA-IR, and Hyperlipidemia in Obese Children from Mexico City: A Cross-Sectional Study. Dermatol Res Pract. 2022;2022:2906189.","journal-title":"Dermatol Res Pract"},{"issue":"Suppl 2","key":"4155_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0300-8932(10)70150-0","volume":"63","author":"JJ Badim\u00f3n","year":"2010","unstructured":"Badim\u00f3n JJ, Santos-Gallego CG, Badim\u00f3n L. Importance of HDL cholesterol in atherothrombosis: how did we get here? Where are we going? Rev Esp Cardiol. 2010;63(Suppl 2):20\u201335.","journal-title":"Rev Esp Cardiol"},{"issue":"9","key":"4155_CR35","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s11886-014-0512-5","volume":"16","author":"CG Santos-Gallego","year":"2014","unstructured":"Santos-Gallego CG, Rosenson RS. Role of HDL in those with diabetes. Curr Cardiol Rep. 2014;16(9):512.","journal-title":"Curr Cardiol Rep"},{"key":"4155_CR36","doi-asserted-by":"crossref","unstructured":"Espinosa-Riquer ZP, Segura-Villalobos D, Ram\u00edrez-Moreno IG, P\u00e9rez Rodr\u00edguez MJ, Lamas M, Gonzalez-Espinosa C: Signal Transduction Pathways Activated by Innate Immunity in Mast Cells: Translating Sensing of Changes into Specific Responses. Cells 2020, 9(11).","DOI":"10.3390\/cells9112411"},{"issue":"9233","key":"4155_CR37","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S0140-6736(00)02690-8","volume":"356","author":"M Rauchhaus","year":"2000","unstructured":"Rauchhaus M, Coats AJ, Anker SD. The endotoxin-lipoprotein hypothesis. Lancet. 2000;356(9233):930\u20133.","journal-title":"Lancet"},{"issue":"4","key":"4155_CR38","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.bcp.2008.04.020","volume":"76","author":"CG Santos-Gallego","year":"2008","unstructured":"Santos-Gallego CG, Ibanez B, Badimon JJ. HDL-cholesterol: is it really good? Differences between apoA-I and HDL. Biochem Pharmacol. 2008;76(4):443\u201352.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"4155_CR39","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s10741-020-09916-0","volume":"26","author":"AO Jackson","year":"2021","unstructured":"Jackson AO, Meng J, Tang H, Yin K. High-density lipoprotein-mediated cardioprotection in heart failure. Heart Fail Rev. 2021;26(4):767\u201380.","journal-title":"Heart Fail Rev"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04155-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-04155-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04155-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T00:03:42Z","timestamp":1728777822000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-04155-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,12]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4155"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-04155-9","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,12]]},"assertion":[{"value":"9 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The need for informed consent was waived by Nanjing Drum Tower Hospital ethical committee because of the retrospective nature of the study.This was a retrospective study in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Nanjing Drum Tower Hospital(2023-428-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"553"}}